Medicare Spending Growth Won't Trigger IPAB Cost Reduction Plan

Threat of Independent Payment Advisory Board action to lower drug spending in Medicare alleviated for another year. Estimated spending growth in the program does not reach targets that would prompt cuts.

Money Wave

Spending in the Medicare program is expected to stay within targets set by the Affordable Care Act over the next few years, avoiding the need for the Independent Payment Advisory Board or HHS to develop a plan this year for reducing costs in the program starting in 2019.

"Because the projected five-year Medicare per capita growth rate does not exceed the Medicare per capita target growth rate, there...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Medicare

More from Government Payers